Porto-sinusoidal vascular liver disorder with portal hypertension: Natural History and Long-Term Outcome.
Options
BORIS DOI
Date of Publication
January 2025
Publication Type
Article
Division/Institute
Author
Magaz, Marta | |
Giudicelli-Lett, Heloïse | |
G Abraldes, Juan | |
Nicoară-Farcău, Oana | |
Turon, Fanny | |
Rajoriya, Neil | |
Goel, Ashish | |
Raymenants, Karlien | |
Hillaire, Sophie | |
Téllez, Luis | |
Elkrief, Laure | |
Procopet, Bogdan | |
Orts, Lara | |
Nery, Filipe | |
Shukla, Akash | |
Larrue, Hélène | |
Degroote, Helena | |
Aguilera, Victoria | |
LLop, Elba | |
Turco, Laura | |
Indulti, Federica | |
Gioia, Stefania | |
Tosetti, Giulia | |
Bitto, Niccolò | |
Alvarado, Edilmar | |
Roig, Cristina | |
Diaz, Raquel | |
Praktiknjo, Michael | |
Konicek, Anna-Lena | |
Olivas, Pol | |
Fortea, José Ignacio | |
Masnou, Helena | |
Puente, Ángela | |
Ardèvol, Alba | |
Navascués, Carmen A | |
Romero-Gutiérrez, Marta | |
Scheiner, Bernhard | |
Semmler, Georg | |
Mandorfer, Mattias | |
Damião, Filipe | |
Baiges, Anna | |
Ojeda, Asunción | |
Simón-Talero, Macarena | |
González-Alayón, Carlos | |
Díaz, Alba | |
García-Criado, Ángeles | |
Hernández-Guerra, Manuel | |
Genescà, Joan | |
Drilhon, Nicolas | |
Ferreira, Carlos Noronha | |
Reiberger, Thomas | |
Morillas, Rosa María | |
Crespo, Javier | |
Trebicka, Jonel | |
Bañares, Rafael | |
Villanueva, Càndid | |
Primignani, Massimo | |
La Mura, Vincenzo | |
Riggio, Oliviero | |
Schepis, Filippo | |
Verhelst, Xavier | |
Calleja, José Luis | |
Bureau, Christophe | |
Albillos, Agustín | |
Nevens, Frederik | |
Hernández-Gea, Virginia | |
Tripathi, Dhiraj | |
Rautou, Pierre-Emmanuel | |
García-Pagán, Juan Carlos |
Subject(s)
Series
Journal of Hepatology
ISSN or ISBN (if monograph)
0168-8278
Publisher
Elsevier
Language
English
Publisher DOI
PubMed ID
39181213
Uncontrolled Keywords
Description
Background & Aims
Current knowledge of the natural history of patients with porto-sinusoidal vascular disorder (PSVD) is derived from small studies. The aim of the present study was to determine natural history and prognostic factors using a large multicenter cohort of PSVD patients.
Methods
Retrospective multicentric study of PSVD patients and signs of portal hypertension (PH) prospectively registered in 27 centers.
Results
587 patients were included, median age of 47 years and 38% were women. Four-hundred and one patient had an associated condition, that was graded as severe in 157. Median follow-up was 68 months. At diagnosis, 64% of patients were asymptomatic while 36% had a PH-related complication: PH-related bleeding in 112 patients; ascites in 117 and hepatic encephalopathy in 11. In those not presenting with bleeding, the incidence of first bleeding was of 15% at 5 years, with a 5-year rebleeding rate of 18%. Five-year cumulative incidence of new or worsening ascites was of 18% and of developing PVT of 16%. Fifty (8.5%) patients received a liver transplantation and 109 (19%) died, including 55 non-liver related death. Transplant-free survival was 97%, and 83% at 1 and 5 years. Variables independently associated with transplant-free survival were age, ascites, serum bilirubin, albumin and creatinine levels at diagnosis and severe associated conditions. This allowed the creation of a Nomogram that accurately predicted prognosis.
Conclusions
Prognosis of PSVD is strongly determined by the severity of the associated underlying conditions and parameters of liver and renal function.
Current knowledge of the natural history of patients with porto-sinusoidal vascular disorder (PSVD) is derived from small studies. The aim of the present study was to determine natural history and prognostic factors using a large multicenter cohort of PSVD patients.
Methods
Retrospective multicentric study of PSVD patients and signs of portal hypertension (PH) prospectively registered in 27 centers.
Results
587 patients were included, median age of 47 years and 38% were women. Four-hundred and one patient had an associated condition, that was graded as severe in 157. Median follow-up was 68 months. At diagnosis, 64% of patients were asymptomatic while 36% had a PH-related complication: PH-related bleeding in 112 patients; ascites in 117 and hepatic encephalopathy in 11. In those not presenting with bleeding, the incidence of first bleeding was of 15% at 5 years, with a 5-year rebleeding rate of 18%. Five-year cumulative incidence of new or worsening ascites was of 18% and of developing PVT of 16%. Fifty (8.5%) patients received a liver transplantation and 109 (19%) died, including 55 non-liver related death. Transplant-free survival was 97%, and 83% at 1 and 5 years. Variables independently associated with transplant-free survival were age, ascites, serum bilirubin, albumin and creatinine levels at diagnosis and severe associated conditions. This allowed the creation of a Nomogram that accurately predicted prognosis.
Conclusions
Prognosis of PSVD is strongly determined by the severity of the associated underlying conditions and parameters of liver and renal function.
File(s)
File | File Type | Format | Size | License | Publisher/Copright statement | Content | |
---|---|---|---|---|---|---|---|
1-s2.0-S0168827824024814-main.pdf | text | Adobe PDF | 3.41 MB | Attribution-NonCommercial-NoDerivatives (CC BY-NC-ND 4.0) | accepted |